2020 Q2 Form 10-Q Financial Statement

#000092661720000037 Filed on May 14, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2020 Q1 2019 Q1
Revenue $746.0K $1.220M $803.0K
YoY Change -34.68% 51.93% 23.73%
Cost Of Revenue $593.0K $800.0K $694.0K
YoY Change -34.69% 15.27% -13.57%
Gross Profit $153.0K $420.0K $109.0K
YoY Change -34.62% 285.32% -170.78%
Gross Profit Margin 20.51% 34.43% 13.57%
Selling, General & Admin $3.599M $3.825M $3.619M
YoY Change -16.57% 5.69% 42.54%
% of Gross Profit 2352.29% 910.71% 3320.18%
Research & Development $380.0K $395.0K $209.0K
YoY Change 68.89% 89.0% 47.18%
% of Gross Profit 248.37% 94.05% 191.74%
Depreciation & Amortization $50.00K $56.00K $124.0K
YoY Change -50.0% -54.84% -33.33%
% of Gross Profit 32.68% 13.33% 113.76%
Operating Expenses $3.979M $4.220M $3.828M
YoY Change -12.34% 10.24% 42.78%
Operating Profit -$3.826M -$3.800M -$3.719M
YoY Change -11.13% 2.18% 31.18%
Interest Expense $0.00 $10.00K $10.00K
YoY Change 0.0% -200.0%
% of Operating Profit
Other Income/Expense, Net -$6.000K $86.00K -$4.000K
YoY Change -14.29% -2250.0% 33.33%
Pretax Income -$3.830M -$3.710M -$3.720M
YoY Change -11.14% -0.27% 30.53%
Income Tax
% Of Pretax Income
Net Earnings -$3.831M -$3.706M -$3.716M
YoY Change -11.2% -0.27% 30.39%
Net Earnings / Revenue -513.54% -303.77% -462.76%
Basic Earnings Per Share
Diluted Earnings Per Share -$39.03K -$38.13K -$49.26K
COMMON SHARES
Basic Shares Outstanding 97.38M 97.29M 75.53M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.90M $8.100M $6.200M
YoY Change -32.72% 30.65% 100.0%
Cash & Equivalents $10.94M $8.132M $6.174M
Short-Term Investments
Other Short-Term Assets $900.0K $800.0K $600.0K
YoY Change 80.0% 33.33% 20.0%
Inventory $100.0K $63.00K $98.00K
Prepaid Expenses
Receivables $800.0K $946.0K $699.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.70M $9.986M $7.576M
YoY Change -27.7% 31.81% 72.18%
LONG-TERM ASSETS
Property, Plant & Equipment $400.0K $318.0K $531.0K
YoY Change -15.25% -40.11% -46.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $41.00K $49.00K $147.0K
YoY Change -64.35% -66.67%
Total Long-Term Assets $391.0K $367.0K $678.0K
YoY Change -33.39% -45.87% -32.2%
TOTAL ASSETS
Total Short-Term Assets $12.70M $9.986M $7.576M
Total Long-Term Assets $391.0K $367.0K $678.0K
Total Assets $13.09M $10.35M $8.254M
YoY Change -27.88% 25.43% 52.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.122M $1.595M $1.157M
YoY Change 38.35% 37.86% 44.63%
Accrued Expenses $2.459M $2.164M $1.879M
YoY Change -0.57% 15.17% 4.39%
Deferred Revenue
YoY Change
Short-Term Debt $587.0K $194.0K $190.0K
YoY Change 207.33% 2.11% -5.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.199M $3.985M $3.336M
YoY Change 17.92% 19.45% 19.14%
LONG-TERM LIABILITIES
Long-Term Debt $1.615M $1.050M $1.244M
YoY Change 35.03% -15.59% -11.14%
Other Long-Term Liabilities $10.00K $16.00K $37.00K
YoY Change -65.52% -56.76%
Total Long-Term Liabilities $1.625M $1.066M $1.281M
YoY Change 32.65% -16.78% -8.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.199M $3.985M $3.336M
Total Long-Term Liabilities $1.625M $1.066M $1.281M
Total Liabilities $5.824M $5.051M $4.617M
YoY Change 21.69% 9.4% 9.93%
SHAREHOLDERS EQUITY
Retained Earnings -$429.7M -$425.9M -$410.6M
YoY Change 3.55% 3.71%
Common Stock $101.0K $97.00K $75.00K
YoY Change 7.45% 29.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.267M $5.302M $3.637M
YoY Change
Total Liabilities & Shareholders Equity $13.09M $10.35M $8.254M
YoY Change -27.88% 25.43% 52.85%

Cashflow Statement

Concept 2020 Q2 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$3.831M -$3.706M -$3.716M
YoY Change -11.2% -0.27% 30.39%
Depreciation, Depletion And Amortization $50.00K $56.00K $124.0K
YoY Change -50.0% -54.84% -33.33%
Cash From Operating Activities -$3.410M -$3.501M -$3.108M
YoY Change -3.67% 12.64% 31.86%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K $23.00K $49.00K
YoY Change 233.33% -53.06% 104.17%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$100.0K -$23.00K -$48.00K
YoY Change 233.33% -52.08% 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.320M -47.00K -30.00K
YoY Change -53.46% 56.67% -45.45%
NET CHANGE
Cash From Operating Activities -3.410M -3.501M -3.108M
Cash From Investing Activities -100.0K -23.00K -48.00K
Cash From Financing Activities 6.320M -47.00K -30.00K
Net Change In Cash 2.810M -3.571M -3.186M
YoY Change -71.93% 12.08% 30.79%
FREE CASH FLOW
Cash From Operating Activities -$3.410M -$3.501M -$3.108M
Capital Expenditures -$100.0K $23.00K $49.00K
Free Cash Flow -$3.310M -$3.524M -$3.157M
YoY Change -5.7% 11.62% 32.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei City Area Code
CityAreaCode
512
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
12117 Bee Caves Road
CY2020Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Building Three
CY2020Q1 dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 100
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78738
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000926617
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
97377890
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-34810
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
Vermillion, Inc.
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0595156
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
519-0400
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q1 dei Trading Symbol
TradingSymbol
VRML
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1158000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1595000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
924000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
946000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2588000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2164000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
430802000
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
431072000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10144433
CY2019Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019Q4 us-gaap Assets
Assets
13828000
CY2020Q1 us-gaap Assets
Assets
10353000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
13410000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
9986000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9360000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6174000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11703000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8132000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3186000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3571000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Liabilities
Liabilities
5051000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3978000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3985000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
97286157
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
97288657
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
97286157
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
97288657
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
97000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
97000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
694000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
800000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
124000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
56000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2019Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1255000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1710000
CY2019Q1 us-gaap Gross Profit
GrossProfit
109000
CY2020Q1 us-gaap Gross Profit
GrossProfit
420000
CY2020Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
14000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
261000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-87000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
111000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
38000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
43000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-14000
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
11000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
9000
CY2019Q4 us-gaap Inventory Net
InventoryNet
25000
CY2020Q1 us-gaap Inventory Net
InventoryNet
63000
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
193000
CY2020Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
194000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
49000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
15000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10000
CY2019Q4 us-gaap Liabilities
Liabilities
5090000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13828000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10353000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1099000
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1050000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-30000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-47000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3108000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3501000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-3716000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3706000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
3828000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
4220000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3719000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3800000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
39000
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0775
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
65000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
39000
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
32000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
86000
CY2020Q1 us-gaap Payments For Royalties
PaymentsForRoyalties
57500
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
49000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
758000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
845000
CY2019Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
13521000
CY2019Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2092000
CY2019Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
353000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
318000
CY2019Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
47000
CY2020Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
48000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
209000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
395000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-422161000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-425867000
CY2019Q1 us-gaap Revenues
Revenues
803000
CY2020Q1 us-gaap Revenues
Revenues
1220000
CY2019Q1 us-gaap Royalty Expense
RoyaltyExpense
31000
CY2020Q1 us-gaap Royalty Expense
RoyaltyExpense
46000
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
97287461
CY2020Q1 vrml Lessee Operating Lease Liability Payments Due Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsDueRemainderOfFiscalYear
24000
CY2019Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2364000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2115000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
184000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
269000
CY2019Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
181000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
7152000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
3637000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
8738000
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
3000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
75507532
CY2019Q1 vrml Net Increase Decrease In Other Assets Or Other Liabilities For Right Of Use Assets
NetIncreaseDecreaseInOtherAssetsOrOtherLiabilitiesForRightOfUseAssets
147000
CY2020Q1 vrml Net Increase Decrease In Other Assets Or Other Liabilities For Right Of Use Assets
NetIncreaseDecreaseInOtherAssetsOrOtherLiabilitiesForRightOfUseAssets
1000
CY2019Q2 vrml Number Of Completed Public Offerings
NumberOfCompletedPublicOfferings
1

Files In Submission

Name View Source Status
0000926617-20-000037-index-headers.html Edgar Link pending
0000926617-20-000037-index.html Edgar Link pending
0000926617-20-000037.txt Edgar Link pending
0000926617-20-000037-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrml-20200331.xml Edgar Link completed
vrml-20200331.xsd Edgar Link pending
vrml-20200331x10q.htm Edgar Link pending
vrml-20200331xex31_1.htm Edgar Link pending
vrml-20200331xex31_2.htm Edgar Link pending
vrml-20200331xex32_1.htm Edgar Link pending
vrml-20200331_cal.xml Edgar Link unprocessable
vrml-20200331_def.xml Edgar Link unprocessable
vrml-20200331_lab.xml Edgar Link unprocessable
vrml-20200331_pre.xml Edgar Link unprocessable